| Aspirin Desensitization Program |
The Center for Disease Control (CDC) estimates that about 1 in 12 people (about 25 million) have asthma, and the numbers are increasing every year. Consequently, about 40% of asthmatic patients who have nasal polyps and sinusitis are also allergic to aspirin.
As a result, in 2004 Nyack Hospital and John Bosso, M.D., Chief of Allergy and Immunology and Medical Director of Allergy and Asthma Consultants of Rockland and Bergen, created a new Aspirin-Desensitization Program. The first of its kind in the region, this program involves giving patients increasing doses to deter their body’s reactions to the medication in a controlled medical setting.
Since its inception, the program has grown dramatically and has successfully desensitized over 400 patients with Aspirin Exacerbated Respiratory Disease (AERD or Samter’s triad). Clinical improvement has been seen in 85- 90% of the patients treated. Benefits include decreased nasal congestion, fewer nasal polyps, less sinus infections and asthma symptoms, reductions in the need for prednisone and sinus surgery procedures. In addition, most patients have an improvement in their sense of smell and overall quality of life.
Dr. Bosso, a fellowship graduate of the Aspirin Desensitization pioneering Scripps Clinic, has desensitized more patients than any other physician in the Northeastern U.S.; he has more than 25 years experience with aspirin desensitization and the management of Aspirin Exacerbated Respiratory Disease (Samter's triad) so his breadth of knowledge and clinical expertise is unmatched in the region. Our caring and competent Same Day Surgery Nursing Staff has been personally trained by Dr. Bosso to provide an outstanding and professional patient care experience.
For more information about aspirin desensitization and to set up a consultation, please contact Dr. Bosso at 845.353.9600 or 201.666.8500 or visit www.rballergy.com.